VETERA WNV (Canada)

Company: Boehringer Ingelheim Animal Health

West Nile Virus Vaccine, Killed Virus

VETERA WNV Indications

This product has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against west nile virus (WNV). The duration of immunity is at least 12 months. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

This product has also been shown to be effective against viremia, mortality, and neurologic clinical disease due to WNV.

Directions and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1mL dose. Administer a second 1 mL dose intramuscularly in 3 to 4 weeks using a different injection site. Historically, annual revaccination with this product has been recommended. The need for annual booster vaccination has not been established for this product. For advice on revaccination frequency, contact your veterinarian or the manufacturer.

Precautions

Store at 2-8°C. Do not freeze. Do not mix with other products. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

Preservatives: Amphotericin B and gentamicin.

For use in animals only.

Vetera^® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license.

Manufactured by:

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Tel: 1 (888) 637-4251

VLN/PCN 124/1995.20

Distributed by:

Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4

CPN: 1182205.0